Biomarker Testing in Advanced NSCLC: A Pulmonology Perspective
Gaetane C. Michaud, MD
Chief of Interventional Pulmonary Medicine,
NYU Langone Health,
New York, New York
Dr. Michaud discusses how to facilitate a comprehensive diagnostic and molecular profiling of NSCLC through different types of biopsy techniques and sample acquisition tactics, onsite cytology consultations, and strategic use of biopsies
CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC
Case Study
Patient Case: Biomarker Testing in Advanced NSCLC
Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC
IN ADVANCED NSCLC
Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC
Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC
Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC
Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC
